Bilirubin Removal With Therapeutic Plasma Exchange Or Molecular Adsorbent Recirculating System (MARS®) As Treatment For Cholemic Nephropathy In Patients With Cirrhosis and ACLF: A case series.

Introduction: Cholemic nephropathy is an overlooked cause of acute kidney injury (AKI) in patients with advanced cirrhosis and high bilirubin plasma levels (usually above 20mg/dl), due to bilirubin and bile acid deposition in the kidneys. Those deposits have been hypothesized to cause tubular injury. It has no standardized diagnostic criteria or therapeutic strategies.

Pterional vs. mini-pterional craniotomy for intracranial aneurysms: a systematic review and meta-analysis.

The mini-pterional craniotomy (mPT) was designed to be a minimally invasive alternative to the standard pterional (PT) approach. However, it remains unclear which technique produces better results. Thus, we aimed to perform a meta-analysis comparing functional, surgical, and aesthetic outcomes between mPT and PT in intracranial aneurysms.

Spatial variability of nitrous oxide emissions from croplands and unmanaged natural ecosystems across a large environmental gradient.

Atmospheric nitrous oxide (NO) is a potent greenhouse gas, with long atmospheric residence time and a global warming potential 273 times higher than CO. NO emissions are mainly produced from soils and are influenced by biotic and abiotic factors that can be substantially altered by anthropogenic activities, such as land uses, especially when unmanaged natural ecosystems are replaced by croplands or other uses. In this study, we evaluated the spatial variability of NO emissions from croplands (maize, soybean, wheat, and sugar cane crops), paired with the natural grasslands or forests that they replaced across a wide environmental gradient in Argentina, and identified the key drivers governing the spatial variability of NO emissions using structural equation modeling.

Tirofiban vs. aspirin in patients with acute ischemic stroke: A meta-analysis of randomized clinical trials.

Background And Objectives: Antiplatelet therapy is recommended as the standard treatment for patients with acute ischemic stroke (AIS) who, for several reasons, did not receive thrombolysis or thrombectomy. However, whether tirofiban or aspirin provides greater benefits for these patients remains unclear. Therefore, we aimed to perform a meta-analysis comparing the functional outcomes and hemorrhagic risks associated with tirofiban and aspirin in the management of AIS.